Exhibit 16.1
![]() | ![]() |
March 24, 2023
Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, D.C. 20549
Re: | Tengjun Biotechnology Corp. Commission File Number 333-169397 |
Dear Sir or Madam:
We have read the statements under item 4.01 in the Form 8-K dated March 24, 2023, of Tengjun Biotechnology Corp. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Form 8-K.”
Very truly yours, | |
/s/ KCCW Accountancy Corp | |
Diamond Bar, CA |